Immunotherapy Drug Shown Safe and Effective in Treating Hodgkin Lymphoma
June 29, 2017 | By Katie Neith
Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.
Research | Patient Care